According to HSA on Friday,” The updated Spikevax immunization functions in the same way as the original vaccination.”
The updated immunization contains a single element that corresponds to the Omicron XBB, in accordance with international advice. 1. 5 variation.
This indicates that the vaccine still offers protection from existing Omicron subvariants.
The updated vaccine is expected to maintain the favorable benefit-risk harmony of the initial Spikevax bivalent vaccine, and there are no other changes to the value, safety, or efficacy of it, according to HSA.
The specialist took into account both additional information and the” extensive information” from earlier editions of the Spikevax vaccine when reviewing the updated vaccination.
The updated vaccination was” boost the immune responses against the commonplace circulating Omicron subvariants ,” including XBB, according to the extra information. 1. 5, EG. 5, or Eris, and the budding BA. 2.86.
” HSA has determined that the entire evidence supported the approval of the updated Spikevax vaccination based on the sum of information, and with the assistance of both the Medicines Advisory Committee and the Panel of Infectious Diseases Experts.”
As the disease continues to evolve and novel variants appear, regular updating of approved COVID – 19 vaccines may be required.
For modifications include the replacement of stress, antigen, or coding series in accordance with recommendations from other countries.
According to the power,” This strategy has been established for annual influenza vaccines that are updated every six months.”
It further stated that it would deliberately track and evaluate the vaccine’s efficacy and safety data.